Significats de monitoring therapy en anglès

Imaging plays a key role in staging and monitoring therapy (surgical and with tyrosine kinase inhibitors).

A major requirement for cancer immunotherapy is the development of biomarkers for prognosis and for monitoring therapy response.

Bone scintigraphy appears to be the best modality for detection of the masses and marrow lesions and for monitoring therapy.

These assays may have a role in staging, monitoring therapy, purging protocols for autologous bone marrow transplantation, and post therapy follow-up.

Useful clinical applications include staging of primary melanomas, detection of progression from localized to metastatic disease during follow-up, and monitoring therapy of advanced melanomas.

In conclusion, both markers are useful for detection of progression from localized to metastatic disease during follow-up and for monitoring therapy of advanced melanomas.

Positron emission tomography (PET) was applied to evaluate therapeutic effects in patients with advanced head and neck cancer for use in monitoring therapy.